Impact of Multimodal Analgesia in ERAS Protocols on Recovery after Major Abdominal Surgery

Abstract Introduction: Enhanced Recovery after Surgery (ERAS) protocols are designed to optimize postoperative recovery by minimizing physiological stress. One of the key components, multimodal analgesia, combines various pain management techniques to reduce opioid use and improve outcomes. This study explores the role of multimodal analgesia in ERAS protocols for patients undergoing major abdominal surgery, focusing on postoperative recovery and complication rates. Aims of the Study: This study aims to assess the impact of ERAS protocols on pain management, opioid use, recovery time, and complication rates in major abdominal surgery patients. Objectives of the Study 1. To compare pain scores and opioid consumption between ERAS and traditional care groups. 2. To assess recovery time, including length of stay and time to ambulation. 3. To evaluate complications and patient satisfaction. Materials and Methods Study Design: This was a prospective randomized controlled trial. Study Site: The study was conducted at GMC Jammu, a tertiary care center, over one year, from January 2023 to December 2023. Study Population: 100 patients undergoing elective major abdominal surgery were included and randomly assigned to two groups: ERAS (n=50) and traditional care (n=50). Interventions: The ERAS group followed a protocol involving multimodal analgesia (local anesthesia, NSAIDs, acetaminophen, and regional anesthesia), early mobilization, and minimized narcotic use. The traditional care group received standard analgesics and delayed mobilization. Outcome Measures: Primary outcomes included pain scores, opioid consumption, and length of stay. Secondary outcomes included time to ambulation, bowel function recovery, complications, and patient satisfaction.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-02-28
DOI
https://doi.org/10.5281/zenodo.15233978
Primary Topic
Enhanced Recovery After Surgery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of Multimodal Analgesia in ERAS Protocols on Recovery after Major Abdominal Surgery

Zenodo (CERN European Organization for Nuclear Research)
Enhanced Recovery After Surgery
article

Impact of Multimodal Analgesia in ERAS Protocols on Recovery after Major Abdominal Surgery

article en

Abstract

Abstract Introduction: Enhanced Recovery after Surgery (ERAS) protocols are designed to optimize postoperative recovery by minimizing physiological stress. One of the key components, multimodal analgesia, combines various pain management techniques to reduce opioid use and improve outcomes. This study explores the role of multimodal analgesia in ERAS protocols for patients undergoing major abdominal surgery, focusing on postoperative recovery and complication rates. Aims of the Study: This study aims to assess the impact of ERAS protocols on pain management, opioid use, recovery time, and complication rates in major abdominal surgery patients. Objectives of the Study 1. To compare pain scores and opioid consumption between ERAS and traditional care groups. 2. To assess recovery time, including length of stay and time to ambulation. 3. To evaluate complications and patient satisfaction. Materials and Methods Study Design: This was a prospective randomized controlled trial. Study Site: The study was conducted at GMC Jammu, a tertiary care center, over one year, from January 2023 to December 2023. Study Population: 100 patients undergoing elective major abdominal surgery were included and randomly assigned to two groups: ERAS (n=50) and traditional care (n=50). Interventions: The ERAS group followed a protocol involving multimodal analgesia (local anesthesia, NSAIDs, acetaminophen, and regional anesthesia), early mobilization, and minimized narcotic use. The traditional care group received standard analgesics and delayed mobilization. Outcome Measures: Primary outcomes included pain scores, opioid consumption, and length of stay. Secondary outcomes included time to ambulation, bowel function recovery, complications, and patient satisfaction.

Zenodo (CERN European Organization for Nuclear Research)
Advanced Pharma (US)
Openalex Percentile: Top 38%
Enhanced Recovery After Surgery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.